Sign in
Explore the registryTrack Emicizumab's trials

WILL-EMI

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

EmicizumabOngoingRecruitingPhase 3Open NCT06998524 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…